Geneos Wealth Management’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Geneos Wealth Management’s Portfolio LDRS Stock Details LDRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,055	Closed	-$51K	–	2467
2018 Q2	$51K	Hold	2,055	–	–	﹤0.01%	1038
2018 Q1	$50K	Buy	+2,055	New	+$52.8K	﹤0.01%	998

Other funds holding LDRS

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

CAN

Claraphi Advisory Network Aliso Viejo, United States $251M AUM 9.29% 1-Year Est. Return

Geneos Wealth Management's LDRS Position: Q3 2018 in Review

Geneos Wealth Management sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q3 2018, closing a stake of 2,055 shares — an estimated $51K sold.

Geneos Wealth Management first reported a position in LDRS in Q1 2018 and held it in 2 quarters. The position peaked at $51K in Q2 2018. 18 funds tracked by Wall St. Rank hold LDRS as of Q3 2018.

Geneos Wealth Management reported no remaining Innovator IBD ETF Leaders ETF position as of Q3 2018 after selling out during the quarter.
Geneos Wealth Management sold 2,055 Innovator IBD ETF Leaders ETF shares in Q3 2018, an estimated $51K.
Geneos Wealth Management first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 2 quarters.
Geneos Wealth Management's Innovator IBD ETF Leaders ETF position peaked at $51K in Q2 2018.
18 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q3 2018.

Based on Geneos Wealth Management's 13F filing for Q3 2018, filed 7 Sep 2021.